EnteroBiotix newsroom
Filter news by category
EnteroBiotix will be attending Microbiome Movement DDS 2024, Boston
EnteroBiotix will be attending Microbiome Movement DDS, Boston on 10-12 July 2024.
EnteroBiotix will be attending BioEquity Europe 2024, San Sebastian
EnteroBiotix will be attending BioEquity Europe 2024, San Sebastian on 12-14 May 2024.
EnteroBiotix will be attending LSX World Congress 2024, London
EnteroBiotix will be attending LSX World Congress, London on 29/30 April 2024.
EnteroBiotix will be attending BioTrinity 2024, London
EnteroBiotix will be attending BioTrinity, London on 23/24 April 2024.
EnteroBiotix at BioEquity 2023
Our CEO Dr James McIlroy presents at BioEquity covering the potential of our premier full-spectrum, microbiome product platform which prevents and treats disease through the restoration and enhancement of gut microbial ecology.
EnteroBiotix’s CEO Dr James McIlroy will be presenting at the 7th Microbiome Movement Drug Summit, Boston US 2022
This Boston based event is the most comprehensive forum for microbiome drug developers. Email us to arrange meeting up at the event.
EnteroBiotix’s CEO Dr James McIlroy will be presenting at BioTrinity, London 2022
BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry. Email us to arrange meeting up at the event.
Find out more about our donor programme. Visit Number2.org